Article and Video CATEGORIES

Cancer Journey

Search By

Alexandra was born in El Salvador and has always had a very strong desire to do something that allows her to help others. She has worked in Digital Marketing since 2015, gaining experience working with different clients throughout Central America and the US.

She has been involved with cancer very closely in her family and knows that there’s never enough we can do to help cancer patients and families go through this difficult path.

Videoteca de Cáncer de Pulmón en Español 2023
AlexandraGBeneke
Esta serie analiza temas relacionados con el cáncer de pulmón, desde el diagnóstico hasta las opciones de tratamiento, y preguntas y conceptos erróneos comunes.
Author
Alexandra Guandique-Beneke
Image
videoteca de cáncer de pulmón

Como parte de la Videoteca de Cáncer de Pulmón en Español 2023, el Dr. Alejandro R. Calvo, MD, FACP, aborda  temas relacionados con el cáncer de pulmón, desde el diagnóstico hasta las opciones de tratamiento, y preguntas y conceptos erróneos comunes.

Para ver la serie completa de click aquí. 

 

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on